UTI Pathogens Beyond E. coli
While E. coli causes approximately 75% of UTIs, the remaining 25% are primarily caused by Enterococcus faecalis, Proteus mirabilis, Klebsiella species, and Staphylococcus saprophyticus. 1
Primary Non-E. coli Uropathogens
The most recent guideline evidence identifies the following organisms as the main alternative causes of UTI:
In Uncomplicated UTIs
- Staphylococcus saprophyticus: Particularly common in young, sexually active women 1
- Klebsiella species: Second most common after E. coli at approximately 8.7% of cases 2
- Enterococcus faecalis: Frequent cause in both community and healthcare settings 1
- Proteus mirabilis: Associated with alkaline urine and stone formation 1
In Complicated UTIs
The 2024 European Association of Urology guidelines emphasize that complicated UTIs have a broader microbial spectrum with higher antimicrobial resistance 3. The most common organisms include:
- E. coli, Proteus spp., Klebsiella spp.: Remain common but with different resistance patterns 3
- Pseudomonas aeruginosa: Particularly in catheterized patients and those with structural abnormalities 3, 4
- Serratia spp.: More common in healthcare-associated infections 3
- Enterococcus spp.: Increased prevalence in complicated cases 3
Clinical Context Matters
Patient-Specific Considerations
Postmenopausal women and those with risk factors for complicated UTIs are more likely to have infections caused by organisms other than E. coli 1. Risk factors that increase likelihood of non-E. coli pathogens include:
- Indwelling catheters 1
- Urinary tract obstruction 1
- Recent instrumentation 3
- Healthcare-associated infections 3
- Diabetes mellitus 1
- Immunosuppression 1
FDA-Approved Coverage
The FDA drug labels confirm the spectrum of uropathogens requiring coverage:
Ciprofloxacin is indicated for UTIs caused by E. coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Providencia rettgeri, Morganella morganii, Citrobacter species, Pseudomonas aeruginosa, Staphylococcus epidermidis, Staphylococcus saprophyticus, and Enterococcus faecalis 4
Trimethoprim-sulfamethoxazole covers E. coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis, and Proteus vulgaris 5
Amoxicillin-clavulanate targets beta-lactamase-producing isolates of E. coli, Klebsiella species, and Enterobacter species 6
Geographic and Resistance Patterns
Recent research demonstrates that Coagulase-negative Staphylococcus (CoNS) accounts for 21.7% of UTI isolates in some populations, making it the second most common pathogen after E. coli 7. This highlights geographic variability in pathogen distribution that clinicians must consider when selecting empiric therapy.
Key Clinical Pitfall
Do not assume all UTIs are caused by E. coli, especially in patients with complicated UTIs, recent antibiotic exposure, healthcare contact, or structural urinary tract abnormalities 1, 3. These patients require urine culture and susceptibility testing before finalizing antibiotic selection, as the broader microbial spectrum and higher resistance rates make empiric therapy less reliable 3.